Loading…

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and its fibrotic complication

Excessive accumulation of reactive oxygen and nitrogen species (RONS) and dysbiosis of intestinal microbiota are pivotal symptoms for inflammatory bowel disease (IBD) and its associated complications, such as intestinal fibrosis. This research introduces a probiotic inulin hydrogel loaded with polyp...

Full description

Saved in:
Bibliographic Details
Published in:Nature communications 2024-09, Vol.15 (1), p.8428-19, Article 8428
Main Authors: Cao, Xiangjing, Tao, Shi, Wang, Weitao, Wu, Silong, Hong, Yang, Wang, Xuyuan, Ma, Yan, Qian, Haisheng, Zha, Zhengbao
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c422t-c4eeca7ba56aa74dfb407120b67af1e8d59559d5e3b60ab83dba76fd963599633
container_end_page 19
container_issue 1
container_start_page 8428
container_title Nature communications
container_volume 15
creator Cao, Xiangjing
Tao, Shi
Wang, Weitao
Wu, Silong
Hong, Yang
Wang, Xuyuan
Ma, Yan
Qian, Haisheng
Zha, Zhengbao
description Excessive accumulation of reactive oxygen and nitrogen species (RONS) and dysbiosis of intestinal microbiota are pivotal symptoms for inflammatory bowel disease (IBD) and its associated complications, such as intestinal fibrosis. This research introduces a probiotic inulin hydrogel loaded with polypyrrole (PPy) nanozymes and antifibrotic drug pirfenidone (PFD) (PPy/PFD@Inulin gel) designed for the concurrent amelioration of IBD and its fibrotic complication. Upon oral administration, the inulin gel matrix could extend the gastrointestinal residence time of PPy nanozymes and PFD, facilitating the efficient reduction of pro-inflammatory cytokine levels and enhancement of the intestinal epithelial barrier repair as well as the suppression of intestinal fibrosis through sustained RONS scavenging, modulation of gut microbiota and attenuation of the TGF-β/Smad signaling pathway to inhibit fibroblast proliferation. Notably, the PPy/PFD@Inulin gel demonstrated significant prophylactic and therapeutic efficacy in acute and chronic colitis as well as intestinal fibrosis induced by dextran sodium sulfate (DSS) in mouse models. Thus, the engineered ternary PPy/PFD@Inulin gel offered a pioneered paradigm for simultaneous reversal of IBD and its associated complications, such as intestinal fibrosis, in a single therapeutic regimen. Because of its complex pathophysiology, the management of inflammatory bowel disease as well as its fibrotic complication has become a global challenge. Here, the authors show a probiotic inulin hydrogel loaded with polypyrrole (PPy) nanozymes and antifibrotic drug pirfenidone (PFD) (PPy/PFD@Inulin gel) designed for the concurrent amelioration of IBD and its fibrotic complication.
doi_str_mv 10.1038/s41467-024-52722-7
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_55f3b2fb63314cea99d923d68c762f93</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_55f3b2fb63314cea99d923d68c762f93</doaj_id><sourcerecordid>3110815319</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-c4eeca7ba56aa74dfb407120b67af1e8d59559d5e3b60ab83dba76fd963599633</originalsourceid><addsrcrecordid>eNp9Uk1vFSEUnRiNbWr_gAtD4sbNKJ_DsDJav17SxE1dE2aAebww8ASmzfPXy-vU2rqQxYVwzzncezlN8xLBtwiS_l2miHa8hZi2DHOMW_6kOcWQohZxTJ4-OJ805znvYF1EoJ7S580JEYSiHtLT5teVSUGlA3Bh8S6A7UGnOBkPblzZAh_D1BaT5pouJhcXlAfJFBOKiwHYmEB28-KLCiYu2R9q8tqk7MIENh8_ARU0cCUD64YUixvBGOe9d6M60l80z6zy2Zzf7WfNjy-fry6-tZffv24uPly2I8W41GjMqPigWKcUp9oOFHKE4dBxZZHpNROMCc0MGTqohp7oQfHOatERJmogZ81m1dVR7eQ-ubn2K6Ny8vYipkmqVIvzRjJmyYDtUFmIjkYJoQUmuutH3mErjlrvV639MsxGj3UQSflHoo8zwW3lFK8lQpT0AuKq8OZOIcWfS52pnF0ejffrCCVBCArEUAcr9PU_0F1c6m_5FdUjRpCoKLyixhRzTsbeV4OgPFpFrlaR1Sry1iqSV9Krh33cU_4YowLICsg1FSaT_r79H9nf1-XMYg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3110815319</pqid></control><display><type>article</type><title>Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and its fibrotic complication</title><source>Nature_系列刊</source><source>PubMed Central Free</source><source>Publicly Available Content (ProQuest)</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Cao, Xiangjing ; Tao, Shi ; Wang, Weitao ; Wu, Silong ; Hong, Yang ; Wang, Xuyuan ; Ma, Yan ; Qian, Haisheng ; Zha, Zhengbao</creator><creatorcontrib>Cao, Xiangjing ; Tao, Shi ; Wang, Weitao ; Wu, Silong ; Hong, Yang ; Wang, Xuyuan ; Ma, Yan ; Qian, Haisheng ; Zha, Zhengbao</creatorcontrib><description>Excessive accumulation of reactive oxygen and nitrogen species (RONS) and dysbiosis of intestinal microbiota are pivotal symptoms for inflammatory bowel disease (IBD) and its associated complications, such as intestinal fibrosis. This research introduces a probiotic inulin hydrogel loaded with polypyrrole (PPy) nanozymes and antifibrotic drug pirfenidone (PFD) (PPy/PFD@Inulin gel) designed for the concurrent amelioration of IBD and its fibrotic complication. Upon oral administration, the inulin gel matrix could extend the gastrointestinal residence time of PPy nanozymes and PFD, facilitating the efficient reduction of pro-inflammatory cytokine levels and enhancement of the intestinal epithelial barrier repair as well as the suppression of intestinal fibrosis through sustained RONS scavenging, modulation of gut microbiota and attenuation of the TGF-β/Smad signaling pathway to inhibit fibroblast proliferation. Notably, the PPy/PFD@Inulin gel demonstrated significant prophylactic and therapeutic efficacy in acute and chronic colitis as well as intestinal fibrosis induced by dextran sodium sulfate (DSS) in mouse models. Thus, the engineered ternary PPy/PFD@Inulin gel offered a pioneered paradigm for simultaneous reversal of IBD and its associated complications, such as intestinal fibrosis, in a single therapeutic regimen. Because of its complex pathophysiology, the management of inflammatory bowel disease as well as its fibrotic complication has become a global challenge. Here, the authors show a probiotic inulin hydrogel loaded with polypyrrole (PPy) nanozymes and antifibrotic drug pirfenidone (PFD) (PPy/PFD@Inulin gel) designed for the concurrent amelioration of IBD and its fibrotic complication.</description><identifier>ISSN: 2041-1723</identifier><identifier>EISSN: 2041-1723</identifier><identifier>DOI: 10.1038/s41467-024-52722-7</identifier><identifier>PMID: 39341804</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>14/32 ; 14/34 ; 147/135 ; 692/4020/1503/257/1389 ; 692/4020/1503/2745 ; 692/699/1503/257/1389 ; Animal models ; Animals ; Colitis ; Colitis - chemically induced ; Colitis - drug therapy ; Colitis - pathology ; Dextran ; Dextran Sulfate ; Dextrans ; Disease Models, Animal ; Dysbacteriosis ; Fibrosis ; Gastrointestinal Microbiome - drug effects ; Humanities and Social Sciences ; Humans ; Hydrogels ; Hydrogels - chemistry ; Inflammatory bowel disease ; Inflammatory bowel diseases ; Inflammatory Bowel Diseases - drug therapy ; Inflammatory Bowel Diseases - pathology ; Intestinal microflora ; Intestinal Mucosa - drug effects ; Intestinal Mucosa - metabolism ; Intestinal Mucosa - pathology ; Intestine ; Intestines - drug effects ; Intestines - microbiology ; Intestines - pathology ; Inulin ; Inulin - chemistry ; Male ; Mice ; Mice, Inbred C57BL ; Microbiota ; Microorganisms ; multidisciplinary ; Oral administration ; Pathophysiology ; Polypyrroles ; Probiotics ; Pyrroles - chemistry ; Reactive nitrogen species ; Reactive oxygen species ; Reactive Oxygen Species - metabolism ; Scavenging ; Science ; Science (multidisciplinary) ; Signal transduction ; Signal Transduction - drug effects ; Smad protein ; Sodium sulfate ; Transforming Growth Factor beta - metabolism ; Transforming growth factor-b</subject><ispartof>Nature communications, 2024-09, Vol.15 (1), p.8428-19, Article 8428</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c422t-c4eeca7ba56aa74dfb407120b67af1e8d59559d5e3b60ab83dba76fd963599633</cites><orcidid>0000-0002-2253-2310 ; 0000-0003-3646-4969 ; 0000-0003-4903-3447</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3110815319/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3110815319?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39341804$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cao, Xiangjing</creatorcontrib><creatorcontrib>Tao, Shi</creatorcontrib><creatorcontrib>Wang, Weitao</creatorcontrib><creatorcontrib>Wu, Silong</creatorcontrib><creatorcontrib>Hong, Yang</creatorcontrib><creatorcontrib>Wang, Xuyuan</creatorcontrib><creatorcontrib>Ma, Yan</creatorcontrib><creatorcontrib>Qian, Haisheng</creatorcontrib><creatorcontrib>Zha, Zhengbao</creatorcontrib><title>Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and its fibrotic complication</title><title>Nature communications</title><addtitle>Nat Commun</addtitle><addtitle>Nat Commun</addtitle><description>Excessive accumulation of reactive oxygen and nitrogen species (RONS) and dysbiosis of intestinal microbiota are pivotal symptoms for inflammatory bowel disease (IBD) and its associated complications, such as intestinal fibrosis. This research introduces a probiotic inulin hydrogel loaded with polypyrrole (PPy) nanozymes and antifibrotic drug pirfenidone (PFD) (PPy/PFD@Inulin gel) designed for the concurrent amelioration of IBD and its fibrotic complication. Upon oral administration, the inulin gel matrix could extend the gastrointestinal residence time of PPy nanozymes and PFD, facilitating the efficient reduction of pro-inflammatory cytokine levels and enhancement of the intestinal epithelial barrier repair as well as the suppression of intestinal fibrosis through sustained RONS scavenging, modulation of gut microbiota and attenuation of the TGF-β/Smad signaling pathway to inhibit fibroblast proliferation. Notably, the PPy/PFD@Inulin gel demonstrated significant prophylactic and therapeutic efficacy in acute and chronic colitis as well as intestinal fibrosis induced by dextran sodium sulfate (DSS) in mouse models. Thus, the engineered ternary PPy/PFD@Inulin gel offered a pioneered paradigm for simultaneous reversal of IBD and its associated complications, such as intestinal fibrosis, in a single therapeutic regimen. Because of its complex pathophysiology, the management of inflammatory bowel disease as well as its fibrotic complication has become a global challenge. Here, the authors show a probiotic inulin hydrogel loaded with polypyrrole (PPy) nanozymes and antifibrotic drug pirfenidone (PFD) (PPy/PFD@Inulin gel) designed for the concurrent amelioration of IBD and its fibrotic complication.</description><subject>14/32</subject><subject>14/34</subject><subject>147/135</subject><subject>692/4020/1503/257/1389</subject><subject>692/4020/1503/2745</subject><subject>692/699/1503/257/1389</subject><subject>Animal models</subject><subject>Animals</subject><subject>Colitis</subject><subject>Colitis - chemically induced</subject><subject>Colitis - drug therapy</subject><subject>Colitis - pathology</subject><subject>Dextran</subject><subject>Dextran Sulfate</subject><subject>Dextrans</subject><subject>Disease Models, Animal</subject><subject>Dysbacteriosis</subject><subject>Fibrosis</subject><subject>Gastrointestinal Microbiome - drug effects</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Hydrogels</subject><subject>Hydrogels - chemistry</subject><subject>Inflammatory bowel disease</subject><subject>Inflammatory bowel diseases</subject><subject>Inflammatory Bowel Diseases - drug therapy</subject><subject>Inflammatory Bowel Diseases - pathology</subject><subject>Intestinal microflora</subject><subject>Intestinal Mucosa - drug effects</subject><subject>Intestinal Mucosa - metabolism</subject><subject>Intestinal Mucosa - pathology</subject><subject>Intestine</subject><subject>Intestines - drug effects</subject><subject>Intestines - microbiology</subject><subject>Intestines - pathology</subject><subject>Inulin</subject><subject>Inulin - chemistry</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Microbiota</subject><subject>Microorganisms</subject><subject>multidisciplinary</subject><subject>Oral administration</subject><subject>Pathophysiology</subject><subject>Polypyrroles</subject><subject>Probiotics</subject><subject>Pyrroles - chemistry</subject><subject>Reactive nitrogen species</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Scavenging</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Signal transduction</subject><subject>Signal Transduction - drug effects</subject><subject>Smad protein</subject><subject>Sodium sulfate</subject><subject>Transforming Growth Factor beta - metabolism</subject><subject>Transforming growth factor-b</subject><issn>2041-1723</issn><issn>2041-1723</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9Uk1vFSEUnRiNbWr_gAtD4sbNKJ_DsDJav17SxE1dE2aAebww8ASmzfPXy-vU2rqQxYVwzzncezlN8xLBtwiS_l2miHa8hZi2DHOMW_6kOcWQohZxTJ4-OJ805znvYF1EoJ7S580JEYSiHtLT5teVSUGlA3Bh8S6A7UGnOBkPblzZAh_D1BaT5pouJhcXlAfJFBOKiwHYmEB28-KLCiYu2R9q8tqk7MIENh8_ARU0cCUD64YUixvBGOe9d6M60l80z6zy2Zzf7WfNjy-fry6-tZffv24uPly2I8W41GjMqPigWKcUp9oOFHKE4dBxZZHpNROMCc0MGTqohp7oQfHOatERJmogZ81m1dVR7eQ-ubn2K6Ny8vYipkmqVIvzRjJmyYDtUFmIjkYJoQUmuutH3mErjlrvV639MsxGj3UQSflHoo8zwW3lFK8lQpT0AuKq8OZOIcWfS52pnF0ejffrCCVBCArEUAcr9PU_0F1c6m_5FdUjRpCoKLyixhRzTsbeV4OgPFpFrlaR1Sry1iqSV9Krh33cU_4YowLICsg1FSaT_r79H9nf1-XMYg</recordid><startdate>20240928</startdate><enddate>20240928</enddate><creator>Cao, Xiangjing</creator><creator>Tao, Shi</creator><creator>Wang, Weitao</creator><creator>Wu, Silong</creator><creator>Hong, Yang</creator><creator>Wang, Xuyuan</creator><creator>Ma, Yan</creator><creator>Qian, Haisheng</creator><creator>Zha, Zhengbao</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7ST</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>SOI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2253-2310</orcidid><orcidid>https://orcid.org/0000-0003-3646-4969</orcidid><orcidid>https://orcid.org/0000-0003-4903-3447</orcidid></search><sort><creationdate>20240928</creationdate><title>Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and its fibrotic complication</title><author>Cao, Xiangjing ; Tao, Shi ; Wang, Weitao ; Wu, Silong ; Hong, Yang ; Wang, Xuyuan ; Ma, Yan ; Qian, Haisheng ; Zha, Zhengbao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-c4eeca7ba56aa74dfb407120b67af1e8d59559d5e3b60ab83dba76fd963599633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>14/32</topic><topic>14/34</topic><topic>147/135</topic><topic>692/4020/1503/257/1389</topic><topic>692/4020/1503/2745</topic><topic>692/699/1503/257/1389</topic><topic>Animal models</topic><topic>Animals</topic><topic>Colitis</topic><topic>Colitis - chemically induced</topic><topic>Colitis - drug therapy</topic><topic>Colitis - pathology</topic><topic>Dextran</topic><topic>Dextran Sulfate</topic><topic>Dextrans</topic><topic>Disease Models, Animal</topic><topic>Dysbacteriosis</topic><topic>Fibrosis</topic><topic>Gastrointestinal Microbiome - drug effects</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Hydrogels</topic><topic>Hydrogels - chemistry</topic><topic>Inflammatory bowel disease</topic><topic>Inflammatory bowel diseases</topic><topic>Inflammatory Bowel Diseases - drug therapy</topic><topic>Inflammatory Bowel Diseases - pathology</topic><topic>Intestinal microflora</topic><topic>Intestinal Mucosa - drug effects</topic><topic>Intestinal Mucosa - metabolism</topic><topic>Intestinal Mucosa - pathology</topic><topic>Intestine</topic><topic>Intestines - drug effects</topic><topic>Intestines - microbiology</topic><topic>Intestines - pathology</topic><topic>Inulin</topic><topic>Inulin - chemistry</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Microbiota</topic><topic>Microorganisms</topic><topic>multidisciplinary</topic><topic>Oral administration</topic><topic>Pathophysiology</topic><topic>Polypyrroles</topic><topic>Probiotics</topic><topic>Pyrroles - chemistry</topic><topic>Reactive nitrogen species</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Scavenging</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Signal transduction</topic><topic>Signal Transduction - drug effects</topic><topic>Smad protein</topic><topic>Sodium sulfate</topic><topic>Transforming Growth Factor beta - metabolism</topic><topic>Transforming growth factor-b</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cao, Xiangjing</creatorcontrib><creatorcontrib>Tao, Shi</creatorcontrib><creatorcontrib>Wang, Weitao</creatorcontrib><creatorcontrib>Wu, Silong</creatorcontrib><creatorcontrib>Hong, Yang</creatorcontrib><creatorcontrib>Wang, Xuyuan</creatorcontrib><creatorcontrib>Ma, Yan</creatorcontrib><creatorcontrib>Qian, Haisheng</creatorcontrib><creatorcontrib>Zha, Zhengbao</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Nature communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cao, Xiangjing</au><au>Tao, Shi</au><au>Wang, Weitao</au><au>Wu, Silong</au><au>Hong, Yang</au><au>Wang, Xuyuan</au><au>Ma, Yan</au><au>Qian, Haisheng</au><au>Zha, Zhengbao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and its fibrotic complication</atitle><jtitle>Nature communications</jtitle><stitle>Nat Commun</stitle><addtitle>Nat Commun</addtitle><date>2024-09-28</date><risdate>2024</risdate><volume>15</volume><issue>1</issue><spage>8428</spage><epage>19</epage><pages>8428-19</pages><artnum>8428</artnum><issn>2041-1723</issn><eissn>2041-1723</eissn><abstract>Excessive accumulation of reactive oxygen and nitrogen species (RONS) and dysbiosis of intestinal microbiota are pivotal symptoms for inflammatory bowel disease (IBD) and its associated complications, such as intestinal fibrosis. This research introduces a probiotic inulin hydrogel loaded with polypyrrole (PPy) nanozymes and antifibrotic drug pirfenidone (PFD) (PPy/PFD@Inulin gel) designed for the concurrent amelioration of IBD and its fibrotic complication. Upon oral administration, the inulin gel matrix could extend the gastrointestinal residence time of PPy nanozymes and PFD, facilitating the efficient reduction of pro-inflammatory cytokine levels and enhancement of the intestinal epithelial barrier repair as well as the suppression of intestinal fibrosis through sustained RONS scavenging, modulation of gut microbiota and attenuation of the TGF-β/Smad signaling pathway to inhibit fibroblast proliferation. Notably, the PPy/PFD@Inulin gel demonstrated significant prophylactic and therapeutic efficacy in acute and chronic colitis as well as intestinal fibrosis induced by dextran sodium sulfate (DSS) in mouse models. Thus, the engineered ternary PPy/PFD@Inulin gel offered a pioneered paradigm for simultaneous reversal of IBD and its associated complications, such as intestinal fibrosis, in a single therapeutic regimen. Because of its complex pathophysiology, the management of inflammatory bowel disease as well as its fibrotic complication has become a global challenge. Here, the authors show a probiotic inulin hydrogel loaded with polypyrrole (PPy) nanozymes and antifibrotic drug pirfenidone (PFD) (PPy/PFD@Inulin gel) designed for the concurrent amelioration of IBD and its fibrotic complication.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>39341804</pmid><doi>10.1038/s41467-024-52722-7</doi><tpages>19</tpages><orcidid>https://orcid.org/0000-0002-2253-2310</orcidid><orcidid>https://orcid.org/0000-0003-3646-4969</orcidid><orcidid>https://orcid.org/0000-0003-4903-3447</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2041-1723
ispartof Nature communications, 2024-09, Vol.15 (1), p.8428-19, Article 8428
issn 2041-1723
2041-1723
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_55f3b2fb63314cea99d923d68c762f93
source Nature_系列刊; PubMed Central Free; Publicly Available Content (ProQuest); Springer Nature - nature.com Journals - Fully Open Access
subjects 14/32
14/34
147/135
692/4020/1503/257/1389
692/4020/1503/2745
692/699/1503/257/1389
Animal models
Animals
Colitis
Colitis - chemically induced
Colitis - drug therapy
Colitis - pathology
Dextran
Dextran Sulfate
Dextrans
Disease Models, Animal
Dysbacteriosis
Fibrosis
Gastrointestinal Microbiome - drug effects
Humanities and Social Sciences
Humans
Hydrogels
Hydrogels - chemistry
Inflammatory bowel disease
Inflammatory bowel diseases
Inflammatory Bowel Diseases - drug therapy
Inflammatory Bowel Diseases - pathology
Intestinal microflora
Intestinal Mucosa - drug effects
Intestinal Mucosa - metabolism
Intestinal Mucosa - pathology
Intestine
Intestines - drug effects
Intestines - microbiology
Intestines - pathology
Inulin
Inulin - chemistry
Male
Mice
Mice, Inbred C57BL
Microbiota
Microorganisms
multidisciplinary
Oral administration
Pathophysiology
Polypyrroles
Probiotics
Pyrroles - chemistry
Reactive nitrogen species
Reactive oxygen species
Reactive Oxygen Species - metabolism
Scavenging
Science
Science (multidisciplinary)
Signal transduction
Signal Transduction - drug effects
Smad protein
Sodium sulfate
Transforming Growth Factor beta - metabolism
Transforming growth factor-b
title Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and its fibrotic complication
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A22%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ternary%20inulin%20hydrogel%20with%20long-term%20intestinal%20retention%20for%20simultaneously%20reversing%20IBD%20and%20its%20fibrotic%20complication&rft.jtitle=Nature%20communications&rft.au=Cao,%20Xiangjing&rft.date=2024-09-28&rft.volume=15&rft.issue=1&rft.spage=8428&rft.epage=19&rft.pages=8428-19&rft.artnum=8428&rft.issn=2041-1723&rft.eissn=2041-1723&rft_id=info:doi/10.1038/s41467-024-52722-7&rft_dat=%3Cproquest_doaj_%3E3110815319%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-c4eeca7ba56aa74dfb407120b67af1e8d59559d5e3b60ab83dba76fd963599633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3110815319&rft_id=info:pmid/39341804&rfr_iscdi=true